Jason Leverone

CFO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

OKUR

Current role

CFO

VRDN

CFO

3 calls Latest call 2021-03-25

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	OnKure Therapeutics, Inc. (OKUR)	C.P.A. Chief Financial Officer	$444,000	—	—	$304,967	$133,200	$14,000	$896,167
2024	OnKure Therapeutics, Inc. (OKUR)	C.P.A. Chief Financial Officer	$382,958	$168,501	—	$2,113,312	—	$13,799	$2,678,570
2023	OnKure Therapeutics, Inc. (OKUR)	C.P.A. Chief Financial Officer	$346,500	$91,476	$311,684	$28,972	—	$13,315	$791,947
2020	Viridian Therapeutics, Inc.\DE (VRDN)	Chief Financial Officer, Treasurer, and Secretary	$365,650	—	—	$112,715	—	$4,655	$483,020
2019	Viridian Therapeutics, Inc.\DE (VRDN)	Chief Financial Officer, Treasurer, and Secretary	$355,000	—	—	$178,223	—	$4,584	$537,807
2018	Viridian Therapeutics, Inc.\DE (VRDN)	Chief Financial Officer	$340,000	—	—	$413,267	$71,400	—	$824,667

Earnings-call appearances and filed executive appointments or departures, newest first.